Pineal transduction. Adrenergic----cyclic AMP-dependent phosphorylation of cytoplasmic 33-kDa protein (MEKA) which binds beta gamma-complex of transducin.
Adrenergic regulation of phosphorylation of pineal proteins was studied. Norepinephrine treatment of intact pinealocytes incubated with 32Pi enhanced phosphorylation of a 33-kDa phosphoprotein (33PP). The effect of NE was rapid, sustained, and appeared to be mediated by a beta-adrenergic----cyclic AMP mechanism. Studies using broken cell preparations revealed that 33PP was phosphorylated by cyclic AMP-dependent protein kinase (PKA). It was also possible to demonstrate PKA-dependent phosphorylation of the 33-kDa protein in cytosol from rat retina and in cow and sheep pineal glands. Two-dimensional polyacrylamide gel electrophoresis revealed that 33PP is acidic (pI congruent to 4.5), appears to exist as two isoforms with slightly different charge, and has the same mobility as the retinal 33-kDa PKA substrate. Immunological analysis indicated 33PP in both tissues is a previously reported 33-kDa protein (MEKA); this protein is a PKA substrate which has been reported to form a cytoplasmic complex with the beta gamma complex of transducin. Consistent with this, it was possible to identify the beta-subunit in pineal cytoplasm and in the same congruent to 70-kDa gel permeation fraction which contained the 33-kDa protein identified as MEKA. Thus, it appears possible that MEKA is present in pineal cytoplasm in a 70-kDa complex with G beta gamma, as is the case in retina. The finding of MEKA in the pineal makes it the latest addition to a family of retinal/pineal proteins which are thought to have evolved from a common ancestral photochemical transduction system.
Reig
J A
JA
Section on Neuroendocrinology, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892.
Yu
L
L
Klein
D C
DC
D000818:Animals; D002417:Cattle; D000242:Cyclic AMP / Q000494:pharmacology*; D003593:Cytoplasm / Q000378:metabolism; D051937:Dopamine and cAMP-Regulated Phosphoprotein 32; D005136:Eye Proteins / Q000378:metabolism*; D005260:Female; D020555:GTP-Binding Protein Regulators; D007545:Isoproterenol / Q000494:pharmacology; D007700:Kinetics; D008970:Molecular Weight; D009419:Nerve Tissue Proteins / Q000378:metabolism; D009638:Norepinephrine / Q000494:pharmacology*; D010656:Phenylephrine / Q000494:pharmacology; D010750:Phosphoproteins; D010766:Phosphorylation; D010870:Pineal Gland / Q000187:drug effects / Q000378:metabolism*; D011494:Protein Kinases / Q000378:metabolism*; D051381:Rats; D011919:Rats, Inbred Strains; D012160:Retina / Q000378:metabolism; D015290:Second Messenger Systems; D012756:Sheep; D015398:Signal Transduction; D015293:Transducin / Q000378:metabolism*
D051937:Dopamine and cAMP-Regulated Phosphoprotein 32; D005136:Eye Proteins; D020555:GTP-Binding Protein Regulators; D009419:Nerve Tissue Proteins; D010750:Phosphoproteins; C065631:phosducin; D010656:Phenylephrine; D000242:Cyclic AMP; D011494:Protein Kinases; D015293:Transducin; D007545:Isoproterenol; D009638:Norepinephrine